Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia
- 10 September 2018
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 58 (10) , 2365-2373
Abstract
BACKGROUND: Patients with acute myeloid leukemia (AML) undergoing consolidation with autologous stem cell transplantation (ASCT) depend on the successful mobilization of peripheral blood stem cells. However, the factors affecting the mobilization potential in AML patients and, in particular, the effect of transfusion‐related iron overload on peripheral blood stem cell mobilization are largely unknown.STUDY DESIGN AND METHODS: We investigated the association of varying levels of iron overload and stem cell mobilization efficacy in consecutive AML patients after two induction cycles.RESULTS: A total of 113 AML patients in early first complete remission underwent the mobilization procedure. While 84 (74.3%) patients had serum ferritin levels exceeding 1000 μg/L, 26 (23.0%) patients had levels even higher than 2000 μg/L. Iron overload correlated with the number of preceding red blood cell transfusions and inversely correlated with circulating CD34+ cell levels (p = 0.04) at apheresis. Finally, the median progression‐free and overall survival rates of patients with ferritin levels of higher than 2000 μg/L were shorter with 332 days versus 2156 days (p = 0.04) and 852 days versus 2235 days (p = 0.04), respectively.CONCLUSION: Our data suggest that transfusion‐related iron overload is suppressing the mobilization potential and is associated with inferior outcome in AML.Keywords
Funding Information
- EMPIRIS Foundation (U.Hecht-Fonds) (#201501)
This publication has 27 references indexed in Scilit:
- Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AMLBone Marrow Transplantation, 2017
- A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patientsBlood, 2015
- Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trialThe Lancet Oncology, 2012
- Autologous peripheral blood stem cell transplantation for acute myeloid leukemiaBlood, 2011
- How I treat patients who mobilize hematopoietic stem cells poorlyBlood, 2011
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- Mobilization of PML/RAR negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxideHaematologica, 2009
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete RemissionJAMA, 2009
- Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantationBone Marrow Transplantation, 2002
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995